Mesothelioma Clinical Trial Results May Be Skewed by Narrow Inclusion Criteria
Australian researchers say too many mesothelioma clinical trial results are skewed because they do not include enough “real world” patients. …
-
-
Asbestos | Compensation | Legal | New Studies | Research
Cosmetic Talc Can Cause Mesothelioma, Study Finds
A new study in the American Journal of Industrial Medicine appears to offer definitive evidence that repeated exposure to cosmetic… -
Possible New Drug for Mesothelioma Gets First FDA Approval
A possible new drug for mesothelioma has received FDA approval for the treatment of advanced epithelioid sarcoma. Tazemetostat (Tazverik) is… -
Surgery Extends Survival for Patients with Pleural Mesothelioma
Patients with pleural mesothelioma who choose to have surgery live longer than those who do not. This applies no matter… -
Targeted Radiotherapy for Mesothelioma May Extend Survival in the Right Patients
A meta-analysis conducted by some of the country’s top cancer researchers says targeted radiotherapy for mesothelioma can help some people… -
Can These Compounds Protect Against the Toxic Effects of Asbestos?
A recent study out of Australia suggests that compounds called zeolites might offer protection against the toxic effects of asbestos.… -
New Studies | Research | Surgery | Treatments
Deep Vein Thrombosis After Pleurectomy for Mesothelioma
The authors of a new study on deep vein thrombosis after pleurectomy say mesothelioma patients may be at special risk.… -
Diagnosis | New Studies | Research | Statistics | Updates
Mesothelioma in Women: Study Reveals Diagnostic Trends
A major study of mesothelioma in women finds that women tend to contract the disease earlier in life than men… -
Immunotherapy with ONCOS-102 Shows Promise for Mesothelioma
Early results are in on the latest trial of immunotherapy with ONCOS-102 and the news is good for pleural mesothelioma… -
Europe | International | New Studies | Research | Updates
Multidisciplinary Care for Mesothelioma
Italian doctors say patients are more likely to enter clinical trials when they have multidisciplinary care for mesothelioma. Inclusion in…
